Skip to main content
Search form
Search
Medicines for Malaria Venture
Developing antimalarials to save lives
Research & Development
MMV's pipeline of antimalarial drugs
R&D areas of work
Next-generation medicines
Products for key populations
Working with regulators
Information for scientists
Malaria online course
Global health compound design webinars
Call for proposals
TPPs & TCPs
Learning resources for scientists
Project of the year award
Computational chemistry
R&D challenges
Access
Products & projects
Antimalarial drug availability
Areas of work
Supporting introduction
Enhancing reach
Informing R&D
Gathering market intelligence
Antimalarial drug toolkits
Artesunate injection dosage & administration
Artesunate rectal capsules tool kit
Seasonal Malaria Chemoprevention tool kit
Access challenges
Partnering
The PDP model
Our partner network
Our donors
Current donors
Past donors
Donate to MMV
Intellectual property rights (IPR)
Clinical centre partners by country
Our impact
Milestones
Malaria stories from the field
Antimalarial drugs for children
Gender equity
Global health security
Antimicrobial resistance to antimalarials
Malaria and COVID-19
About us
What we do
An overview of our work
Our strategic focus
Our history
People & governance
Staff bios
Staff interviews
Board of Directors
MMV North America Board
Expert Scientific Advisory Committee
Access & Product Management Advisory Committee
Global Safety Board
Work with us
Jobs
RFPs/RFIs
Policies
Diversity at MMV
Funding and expenditure
FAQs
Contact us
Malaria & medicines
Definitions and symptoms
5 species of
Plasmodium
parasites
Lifecycle of malaria parasite
Malaria facts & statistics
Malaria treatment
History of antimalarial drugs
Newsroom
News & Press Releases
Audio
Media interviews
Speaking of Malaria podcast
Films
Infographics
Interviews
Image slideshows
Publications
Events
MMV Open
The Global Health Priority Box
About the Global Health Priority Box
Supporting information
Request the Global Health Priority Box
Terms & conditions
Malaria
Libre
Malaria
Libre
open innovation platform
Participate in Malaria
Libre
Malaria
Libre
data repository
MMVSola
About MMVSola
Pandemic Response Box
About the Pandemic Response Box
Request the Pandemic Response Box
Supporting information
Terms & conditions
COVID Box
About the COVID Box
Supporting information
COVID Box terms and conditions
Archived projects
Pathogen Box
Malaria Box
MMV Open Team
Contact us
Home
Newsroom
News
News
Filter
All
R&D
Donors
General
Open source
Partner
Access & product management
All
R&D
Donors
General
Open source
Partner
Access & product management
308 found
46 million reasons and more to celebrate
16 Dec 2022
Holding the line against malaria in 2021 despite ongoing challenges
08 Dec 2022
WHO gives ‘strong recommendation’ supporting use of antimalarial drug to treat pregnant women in the first trimester
28 Nov 2022
RBM Malaria in Pregnancy Working Group meeting in Accra
30 Sep 2022
MMV announces the start of ARCTIC, a feasibility study of a new
Plasmodium vivax
malaria treatment protocol
22 Jul 2022
MMV echoes Fight the Fakes Alliance’s call for Global Fund Replenishment to prevent increase in falsified medicines
14 Jul 2022
MMV awards Project of the Year 2021 to GSK for the discovery of GSK484
12 Jul 2022
MMV’s Dr David Reddy makes commitment at the Kigali Summit
27 Jun 2022
MMV’s CSO Dr Timothy Wells awarded honorary degree from University of Dundee
23 Jun 2022
This World Malaria Day MMV joins Swiss Malaria Group in calling for increased commitment to combatting malaria
22 Apr 2022
MMV welcomes Alan Court as new Board Chair
12 Apr 2022
Dr Pedro Alonso retires from position as Director of WHO’s Global Malaria Programme
01 Apr 2022
Global Health 50/50 launches report
Boards for all?
30 Mar 2022
Professor Michael Ferguson receives British Society for Parasitology Honorary Membership
04 Mar 2022
Ongoing challenges and renewed commitment: MMV’s progress in 2021
14 Dec 2021
MMV supports open letter urging decision makers to scale-up access to preventive malaria treatment in pregnancy
10 Dec 2021
Malaria kills more children than previously estimated according to World Malaria Report
06 Dec 2021
MMV launches innovative drug research tool
01 Dec 2021
MMV deeply saddened by the loss of Dr Martin de Smet
01 Dec 2021
Dr Elizabeth Winzeler elected to the National Academy of Medicine
21 Oct 2021
First real-world use of new protocol for
P. vivax
case management in Brazil – a Health Ministry and MMV collaboration
07 Oct 2021
First-ever malaria vaccine to get WHO recommendation for roll-out
07 Oct 2021
MMV mourns the loss of Dr Tachi Yamada
15 Aug 2021
MMV devises a predictive tool to assess resistance to antimalarial compounds and guide their development
31 May 2021
MMV and DND
i
urge WHO member states to invest in medicines for women and children
27 May 2021
MMV and partners recognize malaria innovations and urge WHO member states to scale up investments
26 May 2021
MMV deeply saddened by the loss of Ambassador Dr Konji Sebati
18 May 2021
MMV recognizes partner Novartis’ milestone of 1 billion courses of antimalarial delivered
18 May 2021
SMC scale-up significantly reduces child mortality in the Sahel
10 May 2021
MMV’s partner S Kant receives WHO prequalification for its protective medicine for children
23 Apr 2021
MMV mourns the loss of Professor Sir Colin Dollery
29 Jan 2021
Republic of Korea grants USD 10 million to MMV-led consortium to protect children from malaria in the Sahel
28 Jan 2021
Looking Back at An Extraordinary Year
18 Dec 2020
MMV awards Project of the Year 2020 to Professor David Fidock and team for critical contribution to malaria drug resistance profiling
18 Dec 2020
MMV’s Adam Aspinall appointed as Chair of the new Fight the Fakes Alliance
14 Dec 2020
World Malaria Report highlights two decades of progress while calling for increased commitment as gains plateau
30 Nov 2020
Despite early indicators of artemisinin resistance in Rwanda, ACTs continue to cure malaria
19 Aug 2020
MMV awards Project of the Year 2019 to Novartis for the discovery of INE963
13 Jul 2020
MMV launches Malaria
Libre
, a new open source drug discovery programme
07 Jul 2020
ESAC member Sir Simon Campbell inducted into the RSC-BMCS Hall of Fame
30 Jun 2020
MMV deeply saddened by the loss of Dr Ricardo Thompson
26 Jun 2020
MMV’s Dr James Duffy appointed to RSC Lectureship
19 Jun 2020
MMV submits statement to 73rd World Health Assembly
19 May 2020
In support of the COVID-19 response
31 Mar 2020
Malaria continues to strike pregnant women and children hardest and new tools are critical, according to WHO’s latest report
05 Dec 2019
MMV presents Lifetime Achievement Awards to three longstanding collaborators
25 Nov 2019
MMV and PATH strengthen ties with APLMA in the fight against relapsing malaria
22 Oct 2019
WHO issues information note about Pyramax® (artesunate-pyronaridine) for uncomplicated malaria
09 Oct 2019
MMV contributes to the fight against schistosomiasis
30 Sep 2019
Via Grand Challenges Africa, MMV supports eight African drug discovery scientists
23 Sep 2019
Two reports on malaria eradication underline need for new tools and interventions
09 Sep 2019
MMV awards its Project of the Year 2018 to University of Dundee researchers
10 Jul 2019
MMV launches new
P. vivax
malaria information hub
26 Jun 2019
Prof Jonathan Vennerstrom receives prestigious ACS Award for Creative Invention
24 Apr 2019
MMV participates in Swiss World Malaria Day event
24 Apr 2019
Professor Michael Ferguson receives Knighthood in New Year’s Honours List
14 Jan 2019
2018 - A triumph of partnerships
19 Dec 2018
Open source effort identifies hundreds of compounds that could protect vulnerable populations from malaria
07 Dec 2018
Access to Medicines Index highlights role of collaboration in stimulating R&D
21 Nov 2018
Fosun Pharma’s medicine to protect pregnant women from malaria first to be approved by WHO
19 Nov 2018
Pages
1
2
3
4
5
6
next ›
last »